Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) parallels the obesity epidemic and associates with components of the metabolic syndrome (MetS). Cholesterol efflux capacity (CEC) represents a key metric of high density lipoprotein (HDL) function which may predict atherosclerotic cardiovascular disease (CVD). Here we interrogated the relationship of CEC with NAFLD.

Source: Atherosclerosis - July 26, 2018 Category: Cardiology Authors: Eline H. van den Berg, Eke G. Gruppen, Sanam Ebtehaj, Stephan J.L. Bakker, Uwe J.F. Tietge, Robin P.F. Dullaart Source Type: research